arrow
G

Gemma Eminowicz

university college london hospitals nhs foundation trust
H指数:17
被引数:1,012

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world treatment patterns, healthcare resource utilization, and costs associated with high-risk endometrial cancer in England: a retrospective cohort study

英格兰高危子宫内膜癌的真实世界治疗模式、医疗资源利用及成本:一项回顾性队列研究

2026-10-010
OA
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK

西地尼布联合每周多西他赛或奥拉帕利与每周多西他赛对比治疗晚期或复发性子宫内膜癌(COPELIA):一项在英国进行的多中心、开放标签、随机、II期临床试验

2026-06-010
OAAI
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel

质量调整的无疾病进展症状或治疗毒性的时间,在原发性晚期或复发性子宫内膜癌患者中使用dostarlimab联合卡铂-紫杉醇治疗与卡铂-紫杉醇治疗相比

2025-05-210
OA
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3trial

局部晚期宫颈癌患者的诱导化疗后标准放化疗与单独标准放化疗 (GCIG INTERLACE): 一项国际多中心随机3期试验

LANCET
IF88.5
2024-10-014
OAAI